Jason Genrich
Known title: DirectorCIK: 0001878758
Jason Genrich's purchase track record
Jason Genrich has only 2 open-market purchases with a full 6 months of price history after it -- too few to call a track record yet.
| Purchase | Stock | Amount | 3 months | 6 months | S&P 500, 6 mo. |
|---|---|---|---|---|---|
| 4/2/2024 | CCI | $2K | -5.9% | +19.2% | +9.7% |
| 1/18/2024 | CCI | $11K | -11.2% | +0.4% | +16.0% |
Computed by MarketWall from SEC Form 4 filings and daily closing prices (close on the purchase date to the close about 3 and 6 months later). Companies that have since delisted are not included. Past results, not investment advice.
Associated companies
Transaction History
| CCI | ▲ Buy | Grant | 1,025 | $0 | 2/25/2026 | View on chart |
| CCI | ▲ Buy | Grant | 2,510 | $0 | 2/26/2025 | View on chart |
| CCI | ▲ Buy | Open Market | 18 | $2K | 4/2/2024 | View on chart |
| CCI | ▲ Buy | Grant | 2,135 | $0 | 2/21/2024 | View on chart |
| CCI | ▲ Buy | Open Market | 99 | $11K | 1/18/2024 | View on chart |
| CCI | ▲ Buy | Grant | 784 | $0 | 1/8/2024 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 17, 2026
Crown Castle Faces Dividend Questions Ahead of Q3 Earnings
Crown Castle is approaching its third-quarter earnings report while investors debate the sustainability of its 6.04% dividend yield. Recent discussions highlight potential AI demand and comparisons with peers like American Tower. The stock currently trades near its 52-week high, with analysts averaging a $94.45 target price.
Crown Castle Faces Dividend Questions Ahead of Q3 Earnings. Crown Castle is approaching its third-quarter earnings report while investors debate the sustainability of its 6.04% dividend yield. Recent discussions highlight potential AI demand and comparisons with peers like American Tower. The stock currently trades near its 52-week high, with analysts averaging a $94.45 target price.